Home/Filings/4/0001225208-23-001906
4//SEC Filing

McEvoy Ashley 4

Accession 0001225208-23-001906

CIK 0000200406other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 4:36 PM ET

Size

9.9 KB

Accession

0001225208-23-001906

Insider Transaction Report

Form 4
Period: 2023-02-10
McEvoy Ashley
EVP, WW Chair, Medical Devices
Transactions
  • Exercise/Conversion

    Common Stock

    2023-02-10+2,99944,811.955 total
  • Tax Payment

    Common Stock

    2023-02-10$162.08/sh823$133,39243,988.955 total
  • Exercise/Conversion

    Restricted Share Units

    2023-02-102,9990 total
    From: 2023-02-10Common Stock (2,999 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    2,723
  • Common Stock

    (indirect: By ESOP)
    300
Footnotes (4)
  • [F1]Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting.
  • [F2]Shares withheld for payment of taxes upon vesting of Restricted Share Units.
  • [F3]Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2023).
  • [F4]Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2023).

Documents

1 file

Issuer

JOHNSON & JOHNSON

CIK 0000200406

Entity typeother

Related Parties

1
  • filerCIK 0001745936

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:36 PM ET
Size
9.9 KB